Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03320226 · ClinicalTrials.gov registry record · NA

A Study of the Effect of Probiotics on Gastrointestinal Function During Pregnancy

A NA study of Pregnancy Early and Nausea Gravidarum, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
39
Enrollment target
1
Study location

NCT03320226 is a NA study of Pregnancy Early and Nausea Gravidarum that has completed, run by University of California, Davis. The registered enrollment target is 39 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03320226, a NA study of Pregnancy Early and Nausea Gravidarum, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target
1
Study location

Study Summary

The purpose as well as the aim of this project is to understand the effect of probiotics on gastrointestinal (GI) dysfunction such as nausea, vomiting, and constipation that are found during the first and second trimesters of pregnancy. The primary objective of this project is to uncover whether probiotics have an effect on GI functional disorders. The secondary objective is to identify the microbiota associated with probiotic intake. The tested hypothesis is that gut microbiota influences the GI functions and may influence constipation, nausea, and vomiting during pregnancy.

Interventions

  • DIETARY_SUPPLEMENT Probiotic 10 (Nature's Bounty)

Study Locations (1)

California

  • University of California, Davis - Sacramento

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2018-01-09
Est. Completion 2021-04-02
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT03320226

The ClinicalTrials.gov registry entry for NCT03320226 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Pregnancy Early appearing as the primary indexed condition, and to 1 intervention - of which Probiotic 10 (Nature's Bounty) is the first listed.

NCT03320226 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03320226 about?

NCT03320226 is a clinical study titled "A Study of the Effect of Probiotics on Gastrointestinal Function During Pregnancy". The purpose as well as the aim of this project is to understand the effect of probiotics on gastrointestinal (GI) dysfunction such as nausea, vomiting, and constipation that are found during the first and second trimesters of pregnancy. The primary objective of this project is to uncover whether pr...

What is the current status of trial NCT03320226?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2018-01-09. Estimated completion is 2021-04-02.

What conditions does trial NCT03320226 study?

This clinical trial studies the following conditions: Pregnancy Early, Nausea Gravidarum, Vomiting of Pregnancy.

What interventions are being tested in trial NCT03320226?

The interventions under investigation include: Probiotic 10 (Nature's Bounty) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03320226?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03320226 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy Early

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.